Research.Patient.info
Age Related Macular Degeneration (ARMD) research hub
2 indexed studies · 1 currently recruiting
- active not recruitingPHASE3
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
This study is looking at a new drug, elamipretide, for dry Age-related Macular Degeneration (AMD). It aims to see if the drug can slow vision loss and if it's safe when given as a daily injection.
United States · Czechia · Germany - recruitingNA
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
This study is looking at a new treatment called i-Lumen AMD, which uses a gentle electric current to help people with a common eye condition called Age-related Macular Degeneration (AMD). The aim is to see if it's safe and effective for slowing down the problem in the eyes.
United States · Australia · New Zealand